VCYT
Veracyte Inc
Price:  
20.84 
USD
Volume:  
736,441.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Veracyte EV/EBITDA

-63.3%
Upside

As of 2024-05-24, the EV/EBITDA ratio of Veracyte Inc (VCYT) is 97.10. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Veracyte's latest enterprise value is 1,384.13 mil USD. Veracyte's TTM EBITDA according to its financial statements is 14.25 mil USD. Dividing these 2 quantities gives us the above Veracyte EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 23.4x - 29.0x 24.8x
Forward P/E multiples 22.9x - 33.1x 28.0x
Fair Price 7.00 - 8.90 7.65
Upside -66.4% - -57.3% -63.3%
20.84 USD
Stock Price
7.65 USD
Fair Price

Veracyte EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-05-24 97.37
2024-05-23 97.10
2024-05-22 101.29
2024-05-21 102.15
2024-05-20 104.94
2024-05-17 108.05
2024-05-16 110.83
2024-05-15 111.64
2024-05-14 108.80
2024-05-13 106.01
2024-05-10 99.95
2024-05-09 95.98
2024-05-08 93.24
2024-05-07 98.12
2024-05-06 97.53
2024-05-03 94.48
2024-05-02 93.62
2024-05-01 93.30
2024-04-30 90.29
2024-04-29 94.42
2024-04-26 88.90
2024-04-25 89.81
2024-04-24 92.06
2024-04-23 91.69
2024-04-22 91.79
2024-04-19 89.65
2024-04-18 88.31
2024-04-17 86.49
2024-04-16 86.81
2024-04-15 89.22
2024-04-12 93.83
2024-04-11 96.51
2024-04-10 96.41
2024-04-09 100.27
2024-04-08 96.30
2024-04-05 93.24
2024-04-04 93.51
2024-04-03 95.98
2024-04-02 95.33
2024-04-01 101.40
2024-03-28 104.18
2024-03-27 101.82
2024-03-26 98.82
2024-03-25 97.96
2024-03-22 98.45
2024-03-21 101.02
2024-03-20 101.23
2024-03-19 101.56
2024-03-18 101.07
2024-03-15 98.50